The healthcare technology company signed a one-year, $480,000 contract to examine the state's public health and healthcare readiness.
The tech giant is now selling its Watch Series 9 and Watch Ultra 2 without a blood oxygen feature.
The company will use the funds to grow its autism therapy practice, continue AI and LLM research, and develop clinical algorithms.
The VC firm's business venture, HATCo, announced it signed a letter of intent to purchase the nonprofit healthcare system and shift its focus to value-based care.
The Wearables for Metabolic Health study will use Fitbit behavioral and biometric data and laboratory tests to attain insights into metabolic health and disease prevention.
Holly Maloney, managing director at General Catalyst, discusses where AI is making waves in healthcare and how digital health funding will progress in 2024.
Also, Qure.ai has received its 13th FDA approval for its AI-based medical imaging software.
The "first aid information shelves" will include instructional videos from authoritative health organizations and be the first search results seen by users.
